2 of the best ASX 50 shares to buy now

Xero Limited (ASX:XRO) and this ASX 50 share have been named as buys. Here’s why they could be among the best shares to buy now…
The post 2 of the best ASX 50 shares to buy now appeared first on The Motley Fool Australia. –

hands holding 5 stars

The S&P/ASX 50 index is home to 50 of the largest listed companies on the Australian share market.

This means the index hosts many of the highest quality and most well-known companies that the ANZ region has to offer.

While not all of the shares on the index are necessarily in the buy zone, two that could be are listed below. Here’s what you need to know about them:

Ramsay Health Care Limited (ASX: RHC)

Ramsay Health Care is an ASX 50 share which could be worth considering. Although 2020 was a difficult year for the private hospital operator because of the pandemic, Ramsay appears to be over the worst of it now and positioned for growth over the long term.

In fact, analysts at Goldman Sachs believe Ramsay can grow its operating earnings at a compound annual growth rate of 7% between FY 2021 and FY 2024.

As a result, they believe its shares are great value at the current level. So much so, Goldman has put a conviction buy rating and $75.00 price target on the company’s shares.

Based on the current Ramsay share price of $63.15, this implies potential upside of almost 19% over the next 12 months.

It commented: “The stock is trading at 8.7x EBITDA for a 7% EBITDA CAGR (FY21-24E), towards the bottom of its 5-year range. We believe the improvement in near-term fundamentals is still not reflected in consensus forecasts or current trading multiples. We raise our 12-month TP to $75 and reiterate our Buy (on CL).”

Xero Limited (ASX: XRO)

Another ASX 50 share to consider is Xero. It is a leading cloud-based business and accounting software provider with a focus on small to medium sized businesses.

Over the last few years Xero’s platform has evolved from an accounting solution into a full service small business solution. This has supported strong growth in customer numbers and ultimately recurring revenues.

Goldman Sachs is also a fan of Xero and believes its growth still has a long way to go. This is due to the quality of its offering, the ongoing shift to cloud-based solutions, its global market opportunity, and burgeoning app ecosystem.

The broker currently has a buy rating and $157.00 price target on the company’s shares. This compares to the current Xero share price of $109.69.

Goldman commented: “…as it broadens and monetizes its app ecosystem, and expands into new geographies, we estimate this will open a further NZ$62bn in addressable TAM, providing a multi-decade runway for strong revenue growth. Combined with attractive unit economics at maturity (GSe 40% EBIT margins), we believe the long-term earnings opportunity for Xero is material.”

Where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

See The 5 Stocks

*Returns as of February 15th 2021

More reading

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of Xero. The Motley Fool Australia has recommended Ramsay Health Care Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post 2 of the best ASX 50 shares to buy now appeared first on The Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!